Related Experiment Video
Updated: Aug 21, 2026

Growing Desmoplastic Three-Dimensional Pancreatic Cancer Spheroids from Co-Culture
Published on: September 27, 2024
Fibroblast growth factor-2 stimulates interleukin-6 secretion in human pancreatic periacinar myofibroblasts
Akira Andoh1, Shigeki Bamba, Sanae Fujino
1Department of Internal Medicine, Shiga University of Medical Science, Otsu, Japan. andoh@belle.shiga-med.ac.jp
Objectives:
Fibroblast growth factor-2 (FGF-2) plays an important role in the pathophysiology of acute and chronic pancreatitis. In the present study, to evaluate the proinflammatory nature of FGF-2, we investigated the effects of FGF-2 on IL-6 secretion in human pancreatic periacinar myofibroblasts.
Methods:
IL-6 supernatant levels were determined by enzyme-linked immunosorbent assays (ELISA). IL-6 mRNA expression were determined by Northern blots and quantitative PCRs. Activated protein (AP)-1 DNA-binding activities were evaluated by electrophoretic gel mobility shift assays (EMSA).
Results:
FGF-2 induced IL-6 release in a dose- and time-dependent manner. FGF-2 activity for IL-6 induction was the same as that of IL-17. The combination of FGF-2 and IL-17 exerted additive effects at mRNA and protein levels. FGF-2 induced AP-1 DNA-binding activity, but blockage of AP-1 signaling by adenovirus-mediated transfer of a dominant negative c-Jun gene did not affect FGF-2-induced IL-6 mRNA expression. FGF-2 rapidly induced activation of ERK1/2 and p38 MAP kinases, and specific inhibitors for these enzymes significantly reduced FGF-2-induced IL-6 release.
Conclusion:
In the pancreas, FGF-2 may not only play a role as a growth factor in tissue injury repair processes but also as an inducer of acute-phase response via stimulation of IL-6 release.
Insights
Fibroblast growth factor-2 (FGF-2) stimulates interleukin-6 (IL-6) release in pancreatic cells, contributing to inflammation. FGF-2 activates specific signaling pathways, highlighting its role in pancreatitis and acute-phase responses.
Area of Science:
- Gastroenterology
- Cell Biology
- Molecular Medicine
Background:
- Fibroblast growth factor-2 (FGF-2) is implicated in pancreatitis pathogenesis.
- Understanding FGF-2's role in pancreatic inflammation is crucial.
Purpose of the Study:
- To investigate the proinflammatory effects of FGF-2 on IL-6 secretion in human pancreatic periacinar myofibroblasts.
- To elucidate the signaling pathways involved in FGF-2-induced IL-6 production.
Main Methods:
- Quantification of IL-6 in supernatants using ELISA.
- Assessment of IL-6 mRNA expression via Northern blots and qPCR.
- Evaluation of AP-1 DNA-binding activity using EMSA.
- Analysis of ERK1/2 and p38 MAP kinase activation.
Main Results:
- FGF-2 dose- and time-dependently induced IL-6 release, comparable to IL-17.
- Combined FGF-2 and IL-17 showed additive effects on IL-6 at mRNA and protein levels.
- FGF-2 activated AP-1, but AP-1 inhibition did not affect FGF-2-induced IL-6 mRNA.
- FGF-2 rapidly activated ERK1/2 and p38 MAP kinases, crucial for IL-6 release.
Conclusions:
- FGF-2 acts as an inducer of the acute-phase response by stimulating IL-6 release in the pancreas.
- Beyond tissue repair, FGF-2 contributes to pancreatic inflammation via IL-6 stimulation.
More Related Videos
Related Concept Videos
Introduction to Fibroblasts
Chronic Pancreatitis II: Pathophysiology
Acute Pancreatitis II: Pathophysiology
Insulin Secretory Vesicles
TGF - β Signaling Pathway
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

